Leishmaniasis 1 Leishmaniasis Species Pathogenic in Humans Leishmania

  • Slides: 27
Download presentation
Leishmaniasis 1

Leishmaniasis 1

Leishmaniasis Species Pathogenic in Humans Leishmania donovani (complex) (VL) Leishmania tropica (CL) Leishmania major

Leishmaniasis Species Pathogenic in Humans Leishmania donovani (complex) (VL) Leishmania tropica (CL) Leishmania major (CL) Leishmania aethiopica (CL) Leishmania mexicana (Complex) (CL) Leishmania brazilliensis (complex) (MCL) 2

The Parasite • Phylum Sarcomastigophora • Order Kinetoplastida • Family Trypanosomatidae • Genus Leishmania

The Parasite • Phylum Sarcomastigophora • Order Kinetoplastida • Family Trypanosomatidae • Genus Leishmania 3

Morphology Digenetic Life Cycle • Promasitogte • Insect • Motile • Midgut • Amastigote

Morphology Digenetic Life Cycle • Promasitogte • Insect • Motile • Midgut • Amastigote • Mammalian stage • Non-motile • Intracellular 4

Morphology • Promastigote • Amastigote Flagella Kinetoplast Golgi Nucleus Cytoskeleton 5

Morphology • Promastigote • Amastigote Flagella Kinetoplast Golgi Nucleus Cytoskeleton 5

Promastigote 6

Promastigote 6

Amastigote 7

Amastigote 7

 • Leishmania (Leishman. Donovan or LD bodies). Lying in macrophage cells from liver.

• Leishmania (Leishman. Donovan or LD bodies). Lying in macrophage cells from liver. Giemsa. × 12000. Enlarged by 9. 6. 8

 • A macrophage filled with Leishmania amastigotes. 9

• A macrophage filled with Leishmania amastigotes. 9

Life cycle • The organism is transmitted by the bite of several species of

Life cycle • The organism is transmitted by the bite of several species of blood-feeding sand flies (Phlebotomus) which carries the promastigote in the anterior gut and pharynx • Dogs and rodents are common reservoirs. 10

11

11

Mammalian Hosts • Rodents • Bats • Dogs • Foxes 12

Mammalian Hosts • Rodents • Bats • Dogs • Foxes 12

Vectors Phlebotomine Sandflies 13

Vectors Phlebotomine Sandflies 13

14

14

Clinical Disease • Visceral • Fatal (90% untreated) • Liver • Spleen • Bone

Clinical Disease • Visceral • Fatal (90% untreated) • Liver • Spleen • Bone marrow • Cutaneous • Generally Self- healing • Skin • Mucous membranes SPECTRUM OF DISEASE 15

Initial Infection • • Similar in all species Inoculation of promastigotes Inflammation & chemotaxis

Initial Infection • • Similar in all species Inoculation of promastigotes Inflammation & chemotaxis Receptor mediated phagocytosis Promastigote Amasitgote Transformation 16

Parasite Spread Macrophage lysis & parasite release Lymphatic spread Blood spread Target organs Skin/lymph

Parasite Spread Macrophage lysis & parasite release Lymphatic spread Blood spread Target organs Skin/lymph nodes/spleen/liver/ bone marrow 17

Clinical Manifestation Variable - Incubation 3 -100+ weeks Lowgrade fever Hepato-splenomegaly Bone marrow hyperplasia

Clinical Manifestation Variable - Incubation 3 -100+ weeks Lowgrade fever Hepato-splenomegaly Bone marrow hyperplasia Anemia, Leucopenia & Cachexia Hypergammaglobulinnemia Epistaxis , Proteinuria, Hematuria 18

 • A boy suffering from visceral leishmaniasis. The boy exhibits splenomegaly, distended abdomen

• A boy suffering from visceral leishmaniasis. The boy exhibits splenomegaly, distended abdomen and severe muscle wasting. 19

 • Jaundiced hands of a visceral leishmaniasis patient. 20

• Jaundiced hands of a visceral leishmaniasis patient. 20

 • Enlarged spleen and liver in an autopsy of an infant dying of

• Enlarged spleen and liver in an autopsy of an infant dying of visceral leishmaniasis. 21

Post Kala Azar Dermal Leishmanoid Normally develops <2 years after recovery Recrudescence Restricted to

Post Kala Azar Dermal Leishmanoid Normally develops <2 years after recovery Recrudescence Restricted to skin Rare but varies geographically 22

Cutaneous leishmaniasis of the face. 23

Cutaneous leishmaniasis of the face. 23

A cutaneous leishmaniasis lesion on the arm. 24

A cutaneous leishmaniasis lesion on the arm. 24

INFECTION Sub-clinical or inapparent infection Recovery Death Immune to reinfection Concurrent infection PKDL 25

INFECTION Sub-clinical or inapparent infection Recovery Death Immune to reinfection Concurrent infection PKDL 25

Diagnosis Bone marrow biopsy Spleen or liver biopsy Culture & Histology 26

Diagnosis Bone marrow biopsy Spleen or liver biopsy Culture & Histology 26

Treatment Pentavalent antimony Pentamidine New drugs - New delivery 27

Treatment Pentavalent antimony Pentamidine New drugs - New delivery 27